focus -WSS

focus

author：explore 2025-09-29 21:12:49 - browse：463

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Adam's Take: Intra

WSS

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Yancopoulos of Regeneron works to expand Dupixent success

Judge agrees to delay next hearing in Trump classified documents case

Texas board proposes rules on abortion law emergency exemption

Biden declares emergency in flood

Biden targets hefty hospital 'facility fees' that often surprise patients

Wikipedia

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

As demand for Covid shots wanes, Moderna seeks its next success

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Cancer drug shortages should be causing more outrage

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Tori Bowie and the unacceptable rates of Black maternal death

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Trump demands the U.S. pay no more for drugs than other countries … again

Pregnancy ages women, but effects reverse after delivery

entertainment

U.K. officials, researchers try to ease path for bespoke genetic treatments

Wisconsin governor employs partial veto to fund schools for 4 centuries

Biden targets hefty hospital 'facility fees' that often surprise patients

Readout Newsletter: Illumina, CRISPR, Regeneron

Mirador, a new biotech startup, launches with $400 million

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Wikipedia

leisure time

Wikipedia

explore